Temasek leads Tropic Biosciences' US$28.5m Series B funding round
Add BT as a preferred source
Singapore
BIOTECH startup Tropic Biosciences, which develops high-performance varieties of tropical crops, on Thursday said it has raised US$28.5 million in a Series B round of funding led by Singapore investment firm Temasek Holdings, bringing its total equity funding raised to US$40 million.
The equity round is joined by new investors including Sumitomo Corporation Europe, Genoa Ventures, Agronomics and Skyviews Life Science. Existing investors Tekfen Ventures, Emerald Technology Ventures, Bits x Bites, and the UK Science & Innovation Seed Fund also participated in the round.
TRENDING NOW
Jumbo Seafood to close flagship East Coast Seafood Centre outlet on Sep 30
Shanda co-founder sells Tanglin Hill bungalow for S$76 million
Singapore developer in limbo after Timor-Leste scraps major township project
Trek 2000 shares jump 41.5% after Osim founder Ron Sim drops claims, sells 7.3% stake to Azure Capital
